SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-213213
Filing Date
2005-11-01
Accepted
2005-11-01 17:09:08
Documents
3
Period of Report
2005-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26898
2 PRESS RELEASE dex991.htm EX-99.1 11144
3 GRAPHIC g85981img_1.jpg GRAPHIC 26219
  Complete submission text file 0001193125-05-213213.txt   75865
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 051170559
SIC: 2836 Biological Products, (No Diagnostic Substances)